InvestorsHub Logo
Followers 8
Posts 3492
Boards Moderated 0
Alias Born 10/09/2019

Re: None

Monday, 08/10/2020 7:02:28 PM

Monday, August 10, 2020 7:02:28 PM

Post# of 7376
Even former Chief Scientific Officer of Neuroscience of Pfizer (NYSE:PFE) Michael Ehlers has joined the psychedelic research movement by joining the advisory board of a psychedelic clinics company Field Trip.

"Therapeutic psychedelics are some of the most exciting new approaches being investigated to fight the burgeoning global mental health crisis happening right now," Ehlers said. "It is critical that we make smart investments, develop the research rigorously, and advance this industry in a thoughtful way."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y